TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
Legemiddelansvarsforeningen
Closing information (x1000 NOK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
15,040
|
23,383
|
20,956 |
Financial expenses |
0
![]() |
0
![]() |
0 |
Earnings before taxes |
9,238
|
15,845
|
14,935 |
Total assets |
239,623
|
230,119
|
214,178 |
Current assets |
110,239
|
230,119
|
214,178 |
Current liabilities |
2,094
|
1,504
|
1,407 |
Equity capital |
237,528
|
228,615
|
212,771 |
- share capital |
0
![]() |
0
![]() |
0 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
99.1%
|
99.3%
![]() |
99.3% |
Turnover per employee | |||
Profit as a percentage of turnover |
61.4%
|
67.8%
|
71.3% |
Return on assets (ROA) |
3.9%
|
6.9%
|
7.0% |
Current ratio |
5264.5%
|
15300.5%
|
15222.3% |
Return on equity (ROE) |
3.9%
|
6.9%
|
7.0% |
Change turnover |
-8,343
|
2,427
|
1,190 |
Change turnover % |
-36%
|
12%
|
6% |
Chg. No. of employees | |||
Chg. No. of employees % |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.